A novel organ preservation solution with efficient clearance of red blood cells improves kidney transplantation in a canine model

Table 1 Composition of WMO-II solution

Chamber	Component	Concentration (mmol/L)	Volume (mL)
A	Potassium citrate	23.4–28.6	500
	Sodiumdi hydrogen phosphate	3.6–4.4
	Disodium hydrogen phosphate	22.5–27.5
	Magnesium sulfate	4.5–5.5
	Potassium chloride	1.8–2.2
	Mannitol	143–158
	Adenosine	4.5–5.5
	Acetyl cysteine	4.3–5.8
	Sodium hydroxide	4.3–5.8
	Water for injection
B	Dextran 40	–	500
B	Water for injection		500

ISSN: 2045-3701